POP-OUT | CLOSE
Jump to a Molecule:

HIV protease with saquinavir

PDB ID: 1HXB

HIV protease cleaves viral proteins during maturation of the virus. It is an important target for anti-HIV therapy. This structure includes the drug saquinavir, the first protease inhibitor that was approved for the treatment of HIV.

Read the Molecule of the Month article on HIV-1 Protease.
Discussed Structures from HIV-1 Protease
HIV protease with a peptide-like inhibitor
HIV protease with a peptide-like inhibitor
HIV protease with saquinavir
HIV protease with saquinavir
 3D structure
View in Jmol
Style
Color
Surface
 
 

Sequence Display

  
Select protein chain for sequence and Jmol display

Length: 99
Type:
protein
 
 
 
 

Ligand and Interaction

  
ROC
ROC : (2S)-N-[(2S,3R)-4-[(2S,3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1-phenyl-butan-2-yl]-2-(quinolin-2-ylcarbonylamino)butanediamide
  Jmol | Ligand Explorer
-
ROC:1hxb

Interactions for ROC.


Reference

PDB ID: 1HXB , Pubmed

Novel binding mode of highly potent HIV-proteinase inhibitors incorporating the (R)-hydroxyethylamine isostere.

Krohn, A., Redshaw, S., Ritchie, J.C., Graves, B.J., Hatada, M.H.

Journal: (1991) J.Med.Chem. 34: 3340-3342


External Links